Acromegaly
Annamaria Colao(Federico II University Hospital), Rosario Pivonello(University of Naples Federico II), Alberto M. Pereira(Leiden University Medical Center), Шломо Мелмед(Cedars-Sinai Medical Center), Ludovica F. S. Grasso(University of Naples Federico II), Andrea Giustina(Vita-Salute San Raffaele University), Philippe Chanson(Université Paris-Sud)
Cited by 387
Related Papers
Growth Hormone, Insulin-Like Growth Factors, and the Skeleton
|Endocrine Reviews|2008|894
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas
|Clinical Endocrinology|2006|830
Guidelines for Acromegaly Management: An Update
|The Journal of Clinical Endocrinology & Metabolism|2009|763
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
|The Lancet|2001|643
Complications of Cushing's syndrome: state of the art
|The Lancet Diabetes & Endocrinology|2016|602